1. A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19. (February 2021) Authors: Wagner, Lelia; Haefeli, Walter E.; Merle, Uta; Lorenz, Hanns-Martin; Hohmann, Nicolas; Weiss, Johanna; Theile, Dirk Journal: Cytokine Issue: Volume 138(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 Activity. (19th December 2020) Authors: Mahmoudi, Mazyar; Foerster, Kathrin I.; Burhenne, Jürgen; Weiss, Johanna; Mikus, Gerd; Haefeli, Walter E. Journal: Journal of clinical pharmacology Issue: Volume 61:Number 6(2021) Page Start: 789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges. Issue 3 (15th September 2020) Authors: Longuespée, Rémi; Theile, Dirk; Fresnais, Margaux; Burhenne, Jürgen; Weiss, Johanna; Haefeli, Walter E. Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 3(2021) Page Start: 858 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of Liver Stiffness with Hepatic Expression of Pharmacokinetically Important Genes in Alcoholic Liver Disease. (24th July 2012) Authors: Theile, Dirk; Haefeli, Walter Emil; Seitz, Helmut Karl; Millonig, Gunda; Weiss, Johanna; Mueller, Sebastian Journal: Alcoholism Issue: Volume 37(2013)Supplement 1 Page Start: E17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Autoinhibitory properties of the parent but not of the N‐oxide metabolite contribute to infusion rate‐dependent voriconazole pharmacokinetics. (18th May 2017) Authors: Hohmann, Nicolas; Kreuter, Rebecca; Blank, Antje; Weiss, Johanna; Burhenne, Jürgen; Haefeli, Walter E.; Mikus, Gerd Journal: British journal of clinical pharmacology Issue: Volume 83:Number 9(2017) Page Start: 1954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bosentan enhances in vitro bortezomib's anti‐proliferative potency against multiple myeloma by mechanisms going beyond endothelin receptor blockade. (20th April 2018) Authors: Schäfer, Julia; Weiss, Johanna; Theile, Dirk Journal: British journal of haematology Issue: Volume 184:Number 6(2019) Page Start: 1052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clarithromycin substantially increases steady‐state bosentan exposure in healthy volunteers. (January 2014) Authors: Markert, Christoph; Schweizer, Yvonne; Hellwig, Regina; Wirsching, Theresia; Riedel, Klaus‐Dieter; Burhenne, Juergen; Weiss, Johanna; Mikus, Gerd; Haefeli, Walter E. Journal: British journal of clinical pharmacology Issue: Volume 77:Number 1(2014:Jan.) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comment on "Sweat but no gain": Inhibiting proliferation of multidrug resistant cancer cells with "Ersatzdroges". Issue 9 (10th October 2014) Authors: Theile, Dirk; Weiss, Johanna Journal: International journal of cancer Issue: Volume 136:Issue 9(2015:May 01) Page Start: 2241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Desmethyl bosentan displays a similar in vitro interaction profile as bosentan. (February 2015) Authors: Weiss, Johanna; Baumann, Sybille; Theile, Dirk; Haefeli, Walter Emil Journal: Pulmonary pharmacology & therapeutics Issue: Volume 30(2015:Feb.) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Drug–Drug Interaction Potential of the HBV and HDV Entry Inhibitor Myrcludex B Assessed in vitro. Issue 3 (April 2018) Authors: Blank, Antje; Meier, Katrin; Urban, Stephan; Haefeli, Walter Emil; Weiss, Johanna Journal: Antiviral therapy Issue: Volume 23:Issue 3(2018) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗